SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-014932
Filing Date
2013-03-14
Accepted
2013-03-14 08:56:51
Documents
17
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v332149_10k.htm 10-K 1350230
2 EXHIBIT 10.39 v332149_ex10-39.htm EX-10.39 64683
3 EXHIBIT 21 v332149_ex21.htm EX-21 2106
4 EXHIBIT 23.1 v332149_ex23-1.htm EX-23.1 2730
5 EXHIBIT 23.2 v332149_ex23-2.htm EX-23.2 3043
6 EXHIBIT 31.1 v332149_ex31-1.htm EX-31.1 7419
7 EXHIBIT 31.2 v332149_ex31-2.htm EX-31.2 7284
8 EXHIBIT 32.1 v332149_ex32-1.htm EX-32.1 3414
9 EXHIBIT 32.2 v332149_ex32-2.htm EX-32.2 3497
10 GRAPHIC image_001.jpg GRAPHIC 11886
11 GRAPHIC image_002.jpg GRAPHIC 6795
  Complete submission text file 0001144204-13-014932.txt   9384192

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT bcli-20121231.xml EX-101.INS 1412254
13 XBRL TAXONOMY EXTENSION SCHEMA bcli-20121231.xsd EX-101.SCH 103760
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20121231_cal.xml EX-101.CAL 37439
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20121231_def.xml EX-101.DEF 338133
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20121231_lab.xml EX-101.LAB 594334
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20121231_pre.xml EX-101.PRE 408433
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54365 | Film No.: 13689201
SIC: 2836 Biological Products, (No Diagnostic Substances)